Shandong Anxin Pharmaceutical Co., Ltd.(Laoling site)

Form 483FOIA Uncovered

Issued January 13, 2023

View FDA's Record for This Firm

Source: Third-party index, not matched to FDA. This record came from a third-party Form 483 index rather than from FDA directly, and we have not been able to match it to a document or an inspection FDA publishes. It stays out of the default view for that reason.

ObservationsNot available

Issue DateJanuary 13, 2023

StatusNo Warning Letter

Related Inspections0

Establishment Details

Firm: Shandong Anxin Pharmaceutical Co., Ltd.(Laoling site)
Location: N/A
FEI Number: N/A
Issue Date: January 13, 2023
Country: N/A

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Shandong Anxin Pharmaceutical Co., Ltd.(Laoling site) FDA Form 483, January 13, 2023